Curaleaf Holdings Inc CURA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Curaleaf Receives All Required Competition Law Clearances for Proposed Acquisition of Aurora Cannabis
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability
Curaleaf Acquires Equity Interest in Boone Town Provisions, Expanding New Jersey Footprint to Four Dispensaries
Curaleaf Celebrates Graduation of Inaugural New York Incubator Program Class, Announces Future Cohorts and Multi-State Expansion
Curaleaf Responds to Alberta Securities Commission Decision
Curaleaf Continues Florida Expansion with Port Orange Dispensary Opening
Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
Trading Information
- Previous Close Price
- CA$12.69
- Day Range
- CA$11.77–12.48
- 52-Week Range
- CA$7.77–20.93
- Bid/Ask
- CA$11.80 / CA$11.97
- Shares Outstanding
- 265.00M
- Market Cap
- CA$3.14B
- Volume/Avg
- 294,669 / 366,722
Key Statistics
- Price/Earnings (Normalized)
- 63.42
- Price/Sales
- 1.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,519
- Website
- https://www.curaleaf.com
Valuation
Metric | CURA |
|---|---|
Price/Earnings (Normalized) | 63.42 |
Price/Book Value | 2.80 |
Price/Sales | 1.89 |
Price/Cash Flow | 13.29 |
Price/Earnings
CURA
Financial Strength
Metric | CURA |
|---|---|
Quick Ratio | 0.63 |
Current Ratio | 1.61 |
Interest Coverage | 0.03 |
Quick Ratio
CURA
Profitability
Metric | CURA |
|---|---|
Return on Assets (Normalized) | 0.19% |
Return on Equity (Normalized) | 0.66% |
Return on Invested Capital (Normalized) | 4.81% |
Return on Assets
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|g>hD>$<# | LOCK|jrqN! | $74B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|rpGL!d^ | LOCK|DBjZp | $50B | |||
| Haleon PLC ADR HLN | LOCK|y#>tdn! | LOCK|SX | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|M>X#<<#Y | LOCK|xv | $34B | |||
| Viatris Inc VTRS | LOCK|&w$K@?g | LOCK|^S | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|ml | LOCK|>pw | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|yzV@$? | LOCK|yS | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|j>%rMVK | LOCK|QmC | $5B | |||
| Perrigo Co PLC PRGO | LOCK|<j^hR?% | LOCK|Q?Z | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|!W^b>dd | LOCK|f>tJ | $2B |
United States